Carregant...
Mitochondria-Targeted Antioxidant and Glycolysis Inhibition –Synergistic Therapy in Hepatocellular Carcinoma
BACKGROUND AND AIMS: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related deaths worldwide. Mito-carboxy proxyl (Mito-CP), a lipophilic cationic nitroxide, accumulates in the mitochondria due to the large negative transmembrane potential. Studies have shown that these agents a...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4028966/ https://ncbi.nlm.nih.gov/pubmed/23872912 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CAD.0b013e32836442c6 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|